Yunn‐Fang Ho

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Ann‐Lii Cheng, Chih‐Hung Hsu, Jen‐Kou Lin et al. · PubMed · 2001 · 2.1K citations

Urinary Bladder Cancer, Chemopreventive Agent, Oncology +15

Determination and pharmacokinetic profile of omeprazole in rat blood, brain and bile by microdialysis and high-performance liquid chromatography

F. C. Cheng, Yunn‐Fang Ho, Ling-Chien Hung et al. · Journal of Chromatography A · 2002 · 80 citations

Pharmacological Study, Pharmacokinetic Profile, Medicine +10

The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese

Ruey‐Meei Wu, Cao Cheng, Kai‐Hsiang Chen et al. · Neurology · 2001 · 72 citations

Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of Hepatic<scp>CYP</scp>2C8 and<scp>OATP</scp>1B Drug Substrates

Ming‐Liang Tan, Ping Zhao, Lei Zhang et al. · Clinical Pharmacology & Therapeutics · 2018 · 64 citations · Full text

Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways

Ying-Cheng Chen, Pin-Hsuan Lu, Shiow‐Lin Pan et al. · Biochemical Pharmacology · 2007 · 63 citations

Medicine, Apoptosis, Cell Death +6